Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-17 Purchase |
2021-12-21 3:48 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
117 | $5.29 | $619 | 4,823,286 (Direct) |
View |
2021-12-16 Purchase |
2021-12-20 5:23 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
10,925 | $5.25 | $57,356 | 4,823,169 (Direct) |
View |
2021-12-16 Purchase |
2021-12-20 5:18 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
10,925 | $5.25 | $57,356 | 4,823,169 (Indirect) |
View |
2021-12-09 Purchase |
2021-12-13 4:15 pm |
Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director |
40,000 | $6.24 | $249,600 | 341,769 (Indirect) |
View |
2021-08-11 Sale |
2021-08-12 5:07 pm |
Sensei Biotherapeutics Inc. | SNSE | Pierce Robert Hamilton Chief Scientific Officer |
16,030 | $7.3436 | $117,718 | 0 (Indirect) |
View |
2021-08-06 Sale |
2021-08-10 5:40 pm |
Sensei Biotherapeutics Inc. | SNSE | Pierce Robert Hamilton Chief Scientific Officer |
79,792 | $7.1216 | $568,246 | 16,030 (Indirect) |
View |
2021-05-05 Purchase |
2021-05-06 4:47 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
350 | $12 | $4,200 | 4,812,244 (Direct) |
View |
2021-05-05 Purchase |
2021-05-06 4:34 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
350 | $12 | $4,200 | 4,812,244 (Indirect) |
View |
2021-04-20 Purchase |
2021-04-21 3:52 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
385 | $12.77 | $4,916 | 4,811,894 (Direct) |
View |
2021-04-20 Purchase |
2021-04-21 3:50 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
385 | $12.77 | $4,916 | 4,811,894 (Indirect) |
View |
2021-04-19 Purchase |
2021-04-20 3:37 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
1,965 | $13.38 | $26,292 | 4,811,509 (Indirect) |
View |
2021-04-19 Purchase |
2021-04-20 3:31 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
1,965 | $13.38 | $26,292 | 4,811,509 (Direct) |
View |
2021-04-13 Purchase |
2021-04-14 5:00 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
2,000 | $14 | $28,000 | 4,809,544 (Direct) |
View |
2021-04-13 Purchase |
2021-04-14 4:41 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
2,000 | $14 | $28,000 | 4,809,544 (Indirect) |
View |
2021-04-07 Purchase |
2021-04-08 6:13 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
2,000 | $14 | $28,000 | 4,807,544 (Indirect) |
View |
2021-04-07 Purchase |
2021-04-08 6:12 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
2,000 | $14 | $28,000 | 4,807,544 (Direct) |
View |
2021-04-01 Purchase |
2021-04-02 2:58 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
1,000 | $14 | $14,000 | 4,805,544 (Direct) |
View |
2021-04-01 Purchase |
2021-04-02 2:56 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
1,000 | $14 | $14,000 | 4,805,544 (Indirect) |
View |
2021-03-30 Purchase |
2021-03-31 3:43 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
2,000 | $12 | $24,000 | 4,804,544 (Direct) |
View |
2021-03-30 Purchase |
2021-03-31 3:41 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
2,000 | $12 | $24,000 | 4,804,544 (Indirect) |
View |
2021-03-24 Purchase |
2021-03-25 12:40 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
3,750 | $14.12 | $52,950 | 4,802,544 (Indirect) |
View |
2021-03-24 Purchase |
2021-03-25 12:37 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
3,750 | $14.12 | $52,950 | 4,802,544 (Direct) |
View |
2021-03-23 Purchase |
2021-03-24 4:21 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
10,000 | $14.34 | $143,400 | 4,798,794 (Indirect) |
View |
2021-03-23 Purchase |
2021-03-24 4:19 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
10,000 | $14.34 | $143,400 | 4,798,794 (Direct) |
View |
2021-03-22 Purchase |
2021-03-23 12:34 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
2,183 | $15.02 | $32,789 | 4,788,794 (Direct) |
View |
2021-03-22 Purchase |
2021-03-23 12:32 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
2,183 | $15.02 | $32,789 | 4,788,794 (Indirect) |
View |
2021-03-18 Purchase |
2021-03-19 3:51 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
817 | $15.25 | $12,459 | 4,786,611 (Direct) |
View |
2021-03-18 Purchase |
2021-03-19 3:44 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
817 | $15.25 | $12,459 | 4,786,611 (Indirect) |
View |
2021-03-08 Purchase |
2021-03-10 5:37 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
1,000 | $15.25 | $15,249 | 4,785,794 (Indirect) |
View |
2021-03-08 Purchase |
2021-03-10 5:35 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
1,000 | $15.25 | $15,249 | 4,785,794 (Direct) |
View |
2021-03-05 Purchase |
2021-03-08 4:55 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
8,000 | $13.75 | $110,000 | 4,784,794 (Direct) |
View |
2021-03-05 Purchase |
2021-03-08 4:48 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
8,000 | $13.75 | $110,000 | 4,784,794 (Indirect) |
View |
2021-03-03 Purchase |
2021-03-05 1:57 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
5,000 | $15.16 | $75,800 | 4,776,794 (Direct) |
View |
2021-03-03 Purchase |
2021-03-05 1:55 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
5,000 | $15.16 | $75,800 | 4,776,794 (Indirect) |
View |
2021-03-02 Purchase |
2021-03-03 5:22 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
3,000 | $16.25 | $48,750 | 4,771,794 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2021-08-10 5:38 pm |
N/A N/A |
Sensei Biotherapeutics Inc. | SNSE | Pierce Robert Hamilton Chief Scientific Officer |
0 | $0 | 95,822 (Indirect) |
View |
2021-07-30 Option Award |
2021-08-02 4:20 pm |
N/A 2031-07-29 |
Sensei Biotherapeutics Inc. | SNSE | Humer Kristian Director |
16,667 | $0 | 16,667 (Direct) |
View |
2021-04-01 Option Award |
2021-04-05 08:51 am |
N/A 2031-03-31 |
Sensei Biotherapeutics Inc. | SNSE | English Jessie Director |
16,667 | $0 | 16,667 (Direct) |
View |